ESR1 and breast carcinoma: Here, we show that STAT1 expression is lost or significantly diminished in the neoplastic cells of a subset of human patients with ERα+/PR+ breast cancer relative to normal breast epithelium, suggesting that downregulation of STAT1 is associated with tumor progression.